Proteostasis Therapeutics Company
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Investors
Industry:
Regenerative medicine
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2007
Employees Number:
51-100
Funding Status:
IPO
Total Funding:
105012271
Last Funding Type:
Series B
Register and Claim Ownership